These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30945066)

  • 1. Savings from the EpiPen Authorized Generic: a Retrospective Analysis of Medicaid Data.
    Hernandez I; Shrank WH; Good CB; Gellad WF
    J Gen Intern Med; 2019 Sep; 34(9):1682-1684. PubMed ID: 30945066
    [No Abstract]   [Full Text] [Related]  

  • 2. In brief: Epinephrine auto-injectors for anaphylaxis.
    Med Lett Drugs Ther; 2016 Sep; 58(1503):e120. PubMed ID: 27603965
    [No Abstract]   [Full Text] [Related]  

  • 3. State Medicaid programs missed $220 million in uncaptured savings as generic fluoxetine came to market, 2001-05.
    Kelton CM; Chang LV; Kreling DH
    Health Aff (Millwood); 2013 Jul; 32(7):1204-11. PubMed ID: 23836735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceuticals and medical devices: cost savings.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-20. PubMed ID: 19297717
    [No Abstract]   [Full Text] [Related]  

  • 5. First Generic Epipen Approved.
    Aschenbrenner DS
    Am J Nurs; 2018 Dec; 118(12):23-24. PubMed ID: 30461488
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicaid payment for generic drugs: achieving savings and access.
    Peters CP
    Issue Brief George Wash Univ Natl Health Policy Forum; 2010 Sep; (839):1-16. PubMed ID: 20928958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brand-name versus generic.
    Copeland KR; Boccuzzi SJ
    Health Aff (Millwood); 2007; 26(4):1198-9; author reply 1199. PubMed ID: 17630468
    [No Abstract]   [Full Text] [Related]  

  • 8. Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending.
    Kesselheim AS; Fischer MA; Avorn J
    Health Aff (Millwood); 2006; 25(6):1637-47. PubMed ID: 17102189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceuticals and medical devices: cost savings. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-33. PubMed ID: 23297446
    [No Abstract]   [Full Text] [Related]  

  • 10. Firm- and drug-specific patterns of generic drug payments by US medicaid programs: 1991-2008.
    Kelton CM; Chang LV; Guo JJ; Yu Y; Berry EA; Bian B; Heaton PC
    Appl Health Econ Health Policy; 2014 Apr; 12(2):165-77. PubMed ID: 24550087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-27. PubMed ID: 18345555
    [No Abstract]   [Full Text] [Related]  

  • 12. Prior authorization for Medicaid drugs.
    Iowa Med; 1995 Aug; 85(8):319. PubMed ID: 7558744
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-31. PubMed ID: 28252884
    [No Abstract]   [Full Text] [Related]  

  • 14. Encouraging generic use can yield significant savings.
    Zimmerman C
    Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015.
    Egilman AC; Wallach JD; Ross JS; Dhruva SS
    JAMA Intern Med; 2018 Apr; 178(4):567-569. PubMed ID: 29340562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-31. PubMed ID: 29361657
    [No Abstract]   [Full Text] [Related]  

  • 17. Best medicines for less: we compare drugs for what ails America.
    Consum Rep; 2008 Jan; 73(1):27-9. PubMed ID: 18488284
    [No Abstract]   [Full Text] [Related]  

  • 18. Generic drug cost containment in Medicaid: lessons from five state MAC programs.
    Abramson RG; Harrington CA; Missmar R; Li SP; Mendelson DN
    Health Care Financ Rev; 2004; 25(3):25-34. PubMed ID: 15229994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic drugs versus brand names: switching could save money. Generic drugs have to go through the same FDA approvals as brand names, so they have the same quality.
    Harv Womens Health Watch; 2013 Jul; 20(11):3. PubMed ID: 24818274
    [No Abstract]   [Full Text] [Related]  

  • 20. Savings from generic drug substitution in South Africa--an arithmetical view.
    Djolov GG
    S Afr Med J; 2003 Aug; 93(8):583-4. PubMed ID: 14531114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.